© 2019 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230
Highlights

Vasoptic Medical impresses at ARVO 2017

May 30, 2017

1/3
Please reload

News
Categories

May 30, 2017

May 7th - 11th, Baltimore, MD: Vasoptic Medical Inc. (VMI) takes pride in having actively participated in the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO 2017) which attracted more than 11,000 attendees from over 45 countries t...

April 24, 2017

Vasoptic Medical Inc., an early stage medical device company in Locust Point, is moving toward getting its first Food and Drug Administration approval, propelled by more than $1.5 million in funding.

For full story click here.

November 15, 2016

Title: Ophthalmic examination and disease management with multiple illumination modalities

Patent No. US9492083

October 6, 2016

Vision loss is a serious concern for those with diabetes. By the time symptoms surface, it can be too late to halt the loss of sight.

But M. Jason Brooke and Abhishek Rege, fellow alums of Johns Hopkins’ biomedical engineering graduate program, are developing technology...

September 29, 2016

Universities are the secret weapon of national startup hubs like Silicon Valley and Boston. And over the last few years Baltimore has done its best to follow suit.

Consider spaces like Johns Hopkins’ FastForward incubator, the University of Maryland BioPark and IMET’s H...

September 4, 2016

ARVO Annual Meeting Abstract  |   September 2016

Purpose

The ability to non-invasively acquire quantitative morphological and blood flow measurements in a primary care setting has the potential to enable early and effective diagnoses of debilitating ophtha...

September 3, 2016

ARVO Annual Meeting Abstract  |   September 2016

Purpose

Quantification of retinal blood flow shows promise as an early biomarker for diverse ocular pathologies such as diabetic retinopathy and glaucoma. We have developed a non-invasive retinal imaging dev...

September 2, 2016

ARVO Annual Meeting Abstract  |   September 2016

Purpose

Retinal blood flow (RBF) may offer insights into systemic health, providing physiological markers for disease and recovery. Researchers may benefit from the ability to simultaneously monitor RBF and...

September 1, 2016

ARVO Annual Meeting Abstract  |   September 2016

Purpose

Current methods used in screening for Retinopathy of Prematurity (ROP) are based on guidelines set forth by the International Committee for the Classification of Retinopathy of Prematurity in 2005. H...

July 26, 2016

Three Johns Hopkins BME-associated medical technology companies have been selected by the Maryland Technology Development Corporation (TEDCO) Life Science Investment Fund for financial investment. TEDCO’s Life Science Investment Fund is specifically designed for compan...

Please reload

Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square

May 30, 2017

May 7th - 11th, Baltimore, MD: Vasoptic Medical Inc. (VMI) takes pride in having actively participated in the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO 2017) which attracted more than 11,000 attendees from over 45 countries t...

April 24, 2017

Vasoptic Medical Inc., an early stage medical device company in Locust Point, is moving toward getting its first Food and Drug Administration approval, propelled by more than $1.5 million in funding.

For full story click here.

November 15, 2016

Title: Ophthalmic examination and disease management with multiple illumination modalities

Patent No. US9492083

October 6, 2016

Vision loss is a serious concern for those with diabetes. By the time symptoms surface, it can be too late to halt the loss of sight.

But M. Jason Brooke and Abhishek Rege, fellow alums of Johns Hopkins’ biomedical engineering graduate program, are developing technology...

September 29, 2016

Universities are the secret weapon of national startup hubs like Silicon Valley and Boston. And over the last few years Baltimore has done its best to follow suit.

Consider spaces like Johns Hopkins’ FastForward incubator, the University of Maryland BioPark and IMET’s H...

September 4, 2016

ARVO Annual Meeting Abstract  |   September 2016

Purpose

The ability to non-invasively acquire quantitative morphological and blood flow measurements in a primary care setting has the potential to enable early and effective diagnoses of debilitating ophtha...